Navigation Links
Trius Reports New Findings on Mechanisms of Antibiotic Resistance in MRSA
Date:9/13/2010

SAN DIEGO, Sept. 13 /PRNewswire-FirstCall/ -- Trius Therapeutics, Inc. (Nasdaq: TSRX) today reported  new findings on torezolid phosphate (TR-701), a second generation oxazolidinone antibiotic now in Phase 3 clinical development. The data elucidate the mechanism by which torezolid retains full activity against clinical isolates of Staphylococcus aureus (S. aureus) carrying the cfr gene which confers resistance to first generation oxazolidinones such as linezolid, marketed by Pfizer as Zyvox®.  Hospital outbreaks of linezolid resistant cfr strains of methicillin resistant Staphylococcus aureus (MRSA) have been reported worldwide and increasing use of linezolid may promote further dissemination of this plasmid borne resistance gene. Two separate articles featuring discussion of these data have been published online ahead of print on September 13 in Antimicrobial Agents and Chemotherapy (AAC), a peer-reviewed journal of the American Society for Microbiology.

S. aureus that express the cfr gene possess ribosomes that are structurally altered in a way that inhibits the binding of first generation oxazolidinone antibiotics such as linezolid, as well as the binding of antibiotics of other classes, such as the pleuromutilins, phenicols, lincosamides, and streptogramins. Torezolid's potent activity is preserved against cfr strains of S. aureus due to its unique structural features.

"Recent outbreaks of cfr strains of MRSA have fueled concerns that this pathogen will inevitably proliferate given the broad usage of linezolid and generic antibiotics that select for the plasmid borne cfr resistance gene," said Jeffrey Stein, Ph.D., President and Chief Executive Officer of Trius and corresponding author on the papers.  "The potent activity of torezolid against cfr-positive bacteria diff
'/>"/>

SOURCE Trius Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Trius to Present at the Stifel Nicolaus Healthcare Conference
2. Trius Therapeutics Obtains Special Protocol Assessment With FDA for Phase 3 Study of Torezolid Phosphate
3. Trius Therapeutics Files Registration Statement for Proposed Initial Public Offering
4. Trius Torezolid Antibiotic for the Treatment of Severe Skin Infections Featured at ICAAC Meeting
5. Trius Announces Positive Results From Phase 2 Clinical Trial of Torezolid in Patients With Complicated Skin and Skin Structure Infections
6. Trius Therapeutics Announces Presentations Featuring Torezolid Antibiotic at the 19th European Congress of Clinical Microbiology and Infectious Diseases
7. Trius Completes Enrollment in Phase 2 Clinical Trial Evaluating Torezolid (TR-701) in Patients With Complicated Skin and Skin Structure Infections
8. Trius Antibiotics to be Highlighted in 18 Presentations at ICAAC/IDSA
9. Trius Doses First Patient in Antibacterial Phase 2 Trial
10. PacificGMP Completes GMP Product Fill for Trius Therapeutics
11. Trius Initiates U.S. Phase I Trial for its Oxazolidinone Antibacterial Drug, TR-701
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... June 30, 2015  The MEDevice San Diego Conference, ... an event dedicated to bringing medtech professionals together for ... topics affecting the industry today. This year,s conference will ... and opportunities facing today,s medtech professional in a fun, ... register for MEDevice San Diego, please visit: MEDeviceSD.com. ...
(Date:6/30/2015)... , June 30, 2015 Zynerba Pharmaceuticals, Inc. ... Form S-1 with the U.S. Securities and Exchange Commission (SEC) ... stock. The number of shares to be offered and the ... Jefferies LLC and Piper Jaffray & ... and Canaccord Genuity Inc. and Oppenheimer & Co. Inc. will ...
(Date:6/30/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/54fkmt/global_array ... "Global Array Instruments Market 2015-2019" report to ... market to grow at a CAGR of 12.48 ... array instruments market can be divided into three ... tissue microarrays and cell microarrays. This report covers ...
Breaking Medicine Technology:MEDevice San Diego 2015 Attracts High-Tech Medical Industry 2Zynerba Files Registration Statement for Proposed Initial Public Offering of Common Stock 2Global Array Instruments Market 2015-2019 - Advances in Personalized Medicines with Affymetrix, Agilent Technologies & Illumina Dominating 2
(Date:7/1/2015)... Wis. (PRWEB) , ... July 01, 2015 , ... ... identification (RFID) safety and security solutions, has partnered with WIU Crossroads School in ... Duress Solution. The unique AEDY (Alternative Education for Disruptive Youth) environment of Crossroads ...
(Date:7/1/2015)... ... ... Recent research has revealed that most adults lack confidence in the effectiveness of ... the last Monday of June, Whiter Image Dental will help new dental ... customer’s first popular In-Office 2 Patient Kit. , The In-Office 2 ...
(Date:7/1/2015)... ... 2015 , ... Seldon Technologies, a leading developer of water ... manufacturer, Bebederos Ecologicos / Ottone Meloda to provide clean drinking water to millions ... top environmental legislators by the nation’s foremost conservation organizations, will speak at the ...
(Date:6/30/2015)... , ... July 01, 2015 , ... Avid boxing style ... and Jimi Hendrix Singer Bowl concert posters. The Who and the Rascals also played ... According to Hawley, "The Doors played with the Who backing them up. The ...
(Date:6/30/2015)... Louis, Missouri (PRWEB) , ... July 01, 2015 , ... ... transvaginal mesh lawsuits being managed in a West Virginia federal court. The ... also set a trial date for the 26 cases.¹ , Carey Danis & Lowe ...
Breaking Medicine News(10 mins):Health News:WIU Crossroads School Chooses Help Alert Mobile Staff Duress Pendants from RF Technologies to Safeguard Staff and Students, De-escalate Altercations 2Health News:WIU Crossroads School Chooses Help Alert Mobile Staff Duress Pendants from RF Technologies to Safeguard Staff and Students, De-escalate Altercations 3Health News:Whiter Image Dental Offers New Customers Half-Off Teeth Whitening Kit 2Health News:Clean Drinking Water Now Available to Millions of Mexican Children as a Result of Partnership Between Seldon Technologies and Bebederos Ecologicos / Ottone Meloda 2Health News:Clean Drinking Water Now Available to Millions of Mexican Children as a Result of Partnership Between Seldon Technologies and Bebederos Ecologicos / Ottone Meloda 3Health News:Avid Boxing Style Rock Concert Poster Collector From Vintage Rock Posters Announces Search for 1968 Doors and Jimi Hendrix Singer Bowl Concert Posters 2Health News:Carey Danis & Lowe Comments on New Pretrial Order in Vaginal Mesh Lawsuit 2Health News:Carey Danis & Lowe Comments on New Pretrial Order in Vaginal Mesh Lawsuit 3
... N.Y., Oct. 8 Moog Inc. (NYSE:,MOG.A and ... are adopting,the Moog brand name. The organizations and ... to an expanded product portfolio within a,single, well-established ... continue to be associated with the,products, this event ...
... by Leading Architectural Firms, LISBON, Portugal ... weeks after,awarding two Johns Hopkins University scientists ... for their research in combating blindness, the,Antonio ... medical,research with the groundbreaking of its 300,000-square-foot ...
... safe substitutes for authentic,FDA approved injectables, NEW ... cosmetic injectables are a threat to your looks,and ... Safety. "The,growing acceptance of cosmetic injections for their ... cautions," says Coalition,leader, plastic surgeon Jeffrey Kenkel, MD ...
... Hodgkin lymphoma, a common form of cancer of the ... blood cells (B cells), but have lost a considerable ... phenotype and the characteristics of Hodgkin lymphoma cells are ... Delbrck Center for Molecular Medicine, MDC, Berlin-Buch and Charit ...
... of Defense has awarded The University of Texas Health ... conduct a multi-center clinical trial that could lead to ... both soldiers and civilians -- who require massive blood ... Sciences (CCTS) is contracting with the U.S. Army Institute ...
... closer to understanding the spread of deadly diseases such ... bacteria respond to stress. , The research, published in ... Science , details how a huge molecule called a ... , Scientists from the University of Newcastle in ...
Cached Medicine News:Health News:World Renowned Champalimaud Foundation Extends its Mission with Groundbreaking for Cutting-Edge Research Center 2Health News:World Renowned Champalimaud Foundation Extends its Mission with Groundbreaking for Cutting-Edge Research Center 3Health News:Illegal Botox Scammers a Public Threat 2Health News:Illegal Botox Scammers a Public Threat 3Health News:Illegal Botox Scammers a Public Threat 4Health News:Illegal Botox Scammers a Public Threat 5Health News:Hodgkin lymphoma -- new characteristics discovered 2Health News:Hodgkin lymphoma -- new characteristics discovered 3Health News:UT researchers to study massive transfusion at major trauma centers 2Health News:Protection for stressed-out bacteria identified 2
... The Apollo Knee System has been ... through range of motion of any fixed ... area and low contact stress under loading ... contributes to long-term effectiveness. The universal symmetrical ...
The Advance revision knee system was designed to address the unpredictable nature of revision knee arthroplasty by providing a wide variety of implant and instrument options....
The AGC dual articular knee is indicated for severe primary or revision cases and features a patented unique articulation which allows controlled rotation of the femoral component about a central piv...
... NexGen CRA femoral component is intended ... anteroposterior, and varus/valgus ligament stability, yet ... to inadequate bone stock. The NexGen ... a PMMA precoat surface. This device ...
Medicine Products: